The University of Chicago Header Logo

Connection

Mei-Yin Polley to Trastuzumab

Back to Details
This is a "connection" page, showing publications Mei-Yin Polley has written about Trastuzumab.
Mei-Yin Polley
Connection Strength
0.045
Trastuzumab
  1. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. J Clin Oncol. 2020 12 10; 38(35):4184-4193.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.